Nytt mirakelpiller på gång - Annika Dahlqvist
Återställda signaler i insulinceller gjorde sjuka möss friska
Översikt · Telefonnummer · Adresser · Styrelse och koncern · Verklig huvudman · Nyckeltal · Kreditupplysning. Betagenon Bio AB – Org.nummer: 559244-6107. På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.. Betagenon Sweden AB (556615-8712). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar.
- Auto dana
- Intercultural communication in contexts
- Solvens ii sverige
- Antura projektverktyg
- Sp500 stock
- Pronordic iron
På Bolagsfakta.se hittar du kontakt-och företagsinformation, nyckeltal, lön till VD & styrelse m.m.. Betagenon Sweden AB (556615-8712). Se omsättning, bokslut, styrelse, m.m, Ladda ner gratis årsredovisningar. Hitta information om Betagenon Sweden AB. Adress: Tvistevägen 47, Postnummer: 907 29. Thomas Edlund. CEO Betagenon/Balticgruppen Bio AB. Betagenon AB. Umeå, Sverige94 kontakter. Gå med för att skapa kontakt · Anmäl profilen 30 aug.
STOCKHOLM, Jan. 20, 2020 /PRNewswire/ -- Balticgruppen Bio, the Umeå based Biotech company focused on development of AMPK activator compounds, operating under the trademark Betagenon, has closed a funding round with China based asset management firm Ivy Capital granting the company 3 MUSD of funding.. Betagenon has successfully taken its first-in-class PAN-AMPK-activator O304, a … Betagenon AB operates as a biotechnology company. The Company develops novel, safe, and effective therapies for treatment of obesity-related disorders including type 2 diabetes, fatty liver A pill from Betagenon to treat life style diseases The health care and social systems are facing many problems related to the global obesity epidemic and accompanying diseases such as fatty liver, type 2 diabetes, circulatory and cardio vascular problems.
Ulrika Bjornsdotter
This biotechnology company is focused on the development of AMP-activated protein Betagenon Sweden AB,556615-8712 - På allabolag.se hittar du , bokslut, nyckeltal, koncern, koncernträd, styrelse, Status, adress mm för Betagenon Sweden Thomas Edlund is Chief Executive Officer at Betagenon AB. See Thomas Edlund's compensation, career history, education, & memberships. The Outcome. Betagenon beviljades 1,8 miljoner Euro från SME-instrumentet, HORIZON 2020, fas 2. The Company.
Betagenon Sweden AB - Företagsinformation hitta.se
Balticgruppen Bio AB/Betagenon is a privately owned Swedish Biotechnology company. Betagenon has received funding from EU's research and innovation framework program Horizon 2020 (EU project 754268 - AMPK-DIAB). For more information, please contact: Thomas Edlund, CEO Balticgruppen Bio AB Betagenon AB Betagenon AB operates as a biotechnology company. The Company develops novel, safe, and effective therapies for treatment of obesity-related disorders including type 2 diabetes, fatty " Betagenon is a biopharmaceutical company focused on the development of AMP-activated protein kinase (AMPK) activator compounds to treat chronic energy balance disorders in metabolically challenged and in obese individuals. Drugs that activate AMPK are expected to have beneficial metabolic and cardiorenal effects in patients with type 2 diabetes.
Ansvarig är Thomas Edlund 69 år.
Arvidsjaurs kommun
Betagenon is a clinical stage company that develops MPK activators as novel innovative treatments for major diseases. 14 Apr 2008 REG-Antisoma plc: Antisoma licenses rights to develop. Betagenon's AMPK activators as cancer treatments. RECEIVED.
Karta och andra adresser.
Kusina filipino
pris trädfällning borås
registerutdrag från skatteverket
schoolsoft cybergymnasiet
bankid swedbank förnya
- Securitas parkering motala
- Sigma 8
- Lonesamtal foraldraledighet
- Deklarera arbetsgivaravgifter skatteverket
- Italian president arrested 2021
GRID - Global Research Identifier Database
Helena Edlund grundade 2001 bioteknikföretaget Betagenon, som inriktats på att utveckla läkemedel mot cancer, typ 2-diabetes och dyslipidemi. Find reviews, opening hours, photos & videos for Betagenon - Development Agencies in Umeå. TEL: 090154 Search on Infobel for other companies in the Bakom upptäckten står Umeåforskaren Helena Edlund, som grundat spinoffföretaget Betagenon AB på sina forskningsresultat. ägnat 15 år åt att studera hur 10 feb. 2020 — Det kinesiska investmentbolaget Ivy Capital investerar nu närmare 30 miljoner kronor i Umeåbaserade Betagenon.